Cite

HARVARD Citation

    Wang, D. et al. (2022). A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy. Neuro-oncology. 24 (3), pp. 414-426. [Online]. 
  
Back to record